89 related articles for article (PubMed ID: 22888653)
21. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
22. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma.
Jones B; Sanghera P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):441-8. PubMed ID: 17324531
[TBL] [Abstract][Full Text] [Related]
23. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
Brada M; Thomas G; Elyan S; James N; Hines F; Ashley S; Marsh H; Bell BA; Stenning S
Br J Cancer; 1995 Jun; 71(6):1330-4. PubMed ID: 7779733
[TBL] [Abstract][Full Text] [Related]
24. Volumetric response evaluation after intensity modulated radiotherapy in patients with supratentorial gliomas.
Cho KH; Choi JH; Kim JY; Lee SH; Yoo H; Shin KH; Kim TH; Moon SH; Lee SH; Park HC
Technol Cancer Res Treat; 2012 Feb; 11(1):41-8. PubMed ID: 22181330
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas?
Pinkham MB; Bertrand KC; Olson S; Zarate D; Oram J; Pullar A; Foote MC
J Clin Neurosci; 2014 Jan; 21(1):86-90. PubMed ID: 24090519
[TBL] [Abstract][Full Text] [Related]
27. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
28. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
Rades D; Haatanen T; Schild SE; Dunst J
Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
[TBL] [Abstract][Full Text] [Related]
29. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
[TBL] [Abstract][Full Text] [Related]
30. [The first experience in interstitial brachytherapy for primary and metastatic tumors of the brain].
Bentsion DL; Gvozdev PB; Sakovich VP; Fialko NV; Kolotvinov VS; Baiankina SN
Zh Vopr Neirokhir Im N N Burdenko; 2006; (1):18-21; discussion 21. PubMed ID: 16739930
[TBL] [Abstract][Full Text] [Related]
31. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
33. Multivariate analysis of prognostic factors in 106 patients with malignant glioma.
Salminen E; Nuutinen JM; Huhtala S
Eur J Cancer; 1996 Oct; 32A(11):1918-23. PubMed ID: 8943675
[TBL] [Abstract][Full Text] [Related]
34. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
36. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
37. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
38. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
Devaux BC; O'Fallon JR; Kelly PJ
J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]